MedPage Today

Unable to display image

MedPage Today DAILY HEADLINES FROM MEDPAGE TODAY

Tuesday January 23, 2007

Antidepressants Increase Fracture Risk for Older Patients (CME/CE)
MONTREAL -- Commonly used selective serotonin reuptake inhibitors (SSRIs) may increase the risk of osteoporotic fractures among patients 50 and older, researchers here found.
http://www.medpagetoday.com/Psychiatry/Depression/dh/4904

Selenium Supplements May Slow HIV Progression (CME/CE)
MIAMI -- Selenium supplements appear to slow the progress of HIV, according to interim results of a study conducted here.
http://www.medpagetoday.com/InfectiousDisease/HIVAIDS/dh/4903

Rapid Flu Test Cuts Antibiotic Use in Adults (CME/CE)
ROCHESTER, N.Y. -- When a rapid test catches the flu, it reduces inappropriate use of antibiotics in adults, according to researchers here.
http://www.medpagetoday.com/InfectiousDisease/URItheFlu/dh/4902

Moderate Renal Dysfunction Linked to Hip Fracture in Older Women (CME/CE)
MINNEAPOLIS -- Older women with moderately impaired renal function are at increased risk for hip fractures, particularly trochanter breaks, researchers here reported.
http://www.medpagetoday.com/Nephrology/GeneralNephrology/dh/4901

Compliance Inconsistent for Adjuvant Breast Cancer Therapy (CME/CE)
DUBLIN -- Many women taking tamoxifen as adjuvant breast cancer therapy are halting it well before the optimal five-year therapeutic standard and not substituting an aromatase inhibitor, researchers here reported.
http://www.medpagetoday.com/HematologyOncology/BreastCancer/dh/4900

ASCO GI: When Oncologists Say Risk, Patients Hear Benefit (CME/CE)
ORLANDO -- More that a third of colorectal cancer survivors surveyed said they would be willing to undergo a repeat course of highly toxic therapy for even a minuscule reduction in the risk of recurrence, researchers reported here.
http://www.medpagetoday.com/MeetingCoverage/ASCOGI/dh/4899

ASCO GI: Transplant Shows Best Survival for Local Liver Cancer Therapy (CME/CE)
ORLANDO -- If all things were equal, a new liver would offer the best chance of long term survival for hepatocellular carcinoma -- but these patients make up a heterogeneous group.
http://www.medpagetoday.com/MeetingCoverage/ASCOGI/dh/4894

Older Women with Early Breast Cancer Helped by Adjuvant Radiation (CME/CE)
WINSTON-SALEM, N.C. -- Radiation therapy for most women 65 and older with stage I or II breast cancer helps prevent recurrences or second primaries, determined a multicenter team of investigators.
http://www.medpagetoday.com/HematologyOncology/BreastCancer/dh/4898

ASCO GI: Avastin Gives No Survival Advantage in Advanced Pancreatic Cancer
ORLANDO -- The addition of Avastin (bevacizumab) to Gemzar (gemcitabine) did not improve survival of advanced pancreatic cancer in a randomized trial, researchers here reported.
http://www.medpagetoday.com/MeetingCoverage/ASCOGI/dh/4895

ASCO GI: Investigational Vaccine Extends Post-Op Pancreatic Cancer Survival (CME/CE)
ORLANDO -- An investigational therapeutic vaccine for pancreatic cancer extended survival after surgery by about six to seven months, researchers reported here.
http://www.medpagetoday.com/MeetingCoverage/ASCOGI/dh/4896

ASCO GI: Modest Gain With Avastin for Advanced Colorectal Cancer (CME/CE)
ORLANDO -- Avastin (bevacizumab) added to an Eloxatin (oxaliplatin)-based chemotherapy regimen modestly extended progression-free survival in metastatic colorectal cancer, according to results of a randomized phase III trial.
http://www.medpagetoday.com/MeetingCoverage/ASCOGI/dh/4897

CME Spotlight
For Pharmacists: Antimicrobial Resistance in the Hospital Setting (more...)
Designed for pharmacists, this activity reviews the management of antimicrobial resistance in the hospital setting and discusses strategies to prevent the development of more resistant strains. Source: American Academy of CME, Inc.
Tailoring Antithrombotic Dosing in Select ACS Patients (more...)
This activity describes the risks associated with the improper dosing of anticoagulants, and discusses how to properly modify dosing for patients with ACS. Source: Medical Education Solutions Group (www.MESG.org)
Targeted Treatments for Patients With Advanced NSCLC (more...)
This activity discusses the use of targeted therapies as both first-line and second-line treatment for advanced non-small-cell lung cancer (NSCLC)and treatment options for patients with NSCLC or bronchioloalveolar carcinoma (BAC) who have never smoked. Source: Medscape
Clinicians on the Front Line: Active Management of Depression and Anxiety in Primary Care (more...)
Designed for primary care practitioners, this activity will help participants: a)Identify patients at risk for depression or anxiety, b)Incorporate screening tools to improve detection rates, and c)Select the most appropriate treatment. Source: Boston University School of Medicine
Psychiatry for Primary Care Clinicians: Recognizing and Treating Depression to Achieve Remission (more...)
The activity will provide an opportunity to see and hear A. John Rush, MD, a primary contributor to the development, implementation, and analysis of the results of the STAR-D study, discuss the impact this study will have on the future treatment of major depressive disorder. Source: The University of Pennsylvania School of Medicine
For Pharmacists: New Treatments for Myelodysplastic Syndromes and Multiple Myeloma (more...)
Designed for pharmacists who care for patients with myelodysplastic syndromes (MDS) or multiple myeloma (MM), this CPE webcast explores several new and emerging agents that have shown promising results in treating these challenging cancers. Source: Projects In Knowledge

Resources
Clostridium Difficile Needs Assessment Survey. Click here
We value your feedback! Your responses to this quick, 8-question survey will help us develop educational programs related to clostridium difficile. Thanks for your help!. Source: Institute for Continuing Healthcare Education
Urinary Incontinence Needs Assessment Survey. Click here.
We value your feedback! Your responses to this quick, 10 -question survey will help us develop educational programs related to urinary incontinence. Thanks for your help!. Source: Institute for Continuing Healthcare Education
Learn about a new treatment for advanced cutaneous t-cell lymphoma (CTCL).
Learn about a new treatment for advanced cutaneous t-cell lymphoma (CTCL). Source: Merck.

Featured Job Opportunities from MedJobs Today

Internal Medicine, Florida
Physician, physician assistant or nurse practitioner wanted for a primary care practice.
http://www.medjobstoday.com/seeker/job_detail.cfm?jobid=11982&refsrc=dh

Visit MedJobs Today.com to search for a new job!

At MedPage Today™, we’re PUTTING BREAKING NEWS INTO PRACTICE®.
__________________________________
SUBSCRIPTION INFORMATION

Unsubscribe or change my email settings:
http://www.medpagetoday.com/updemail.cfm

__________________________________
Copyright 2005-2006 MedPage Today, LLC. All Rights Reserved.

MedPage Today, LLC., 150 Clove Road, 10th Floor, Little Falls, NJ 07424, (973) 890-0985

Meeting Coverage

AHA - November

SABCS - December

ASNC - September

ASH: Hematology - December

Exjade Virtual Booth

Experience the complete range of communication and branding via a fully interactive virtual exhibit booth, matching the experience of attendees of the 2006 ASH Annual Meeting.

Source: Novartis Oncology